FIELD: medicine.
SUBSTANCE: invention relates to the field of lipoproteomics, metabolomics, cellular biology, atherogenesis, structural biology, molecular cardiology. The invention pertains to a method for determining the degree of dissociation of an A-I apoprotein. The method includes collecting blood in male patients without atherosclerosis and performing denaturation of high-density lipoprotein (HDL) preparations obtained by precipitation of apoB-containing lipoproteins with polyethylene glycol by urea; measuring the dissociation of apoA-I occurring during denaturation of the HDL by the accumulation of preβ-apoA-I in separation of the HDL by electrophoresis in an agarose gel followed by immunodetection of an apoprotein in a replica of the gel; the effect of induction of dissociation of apoA-I by urea on the functional properties of the HDL is identified by measuring the АВСА1-mediated efflux of a fluorescent cholesterol analogue from the mouse macrophage line RAW 264.7 on the HDL of patients as a cholesterol acceptor. The degree of dissociation of apoA-I (D) is then calculated as the gain in the proportion of preβ-apoA-I relative to the native HDL by the formula.
EFFECT: invention ensures identification of new structural and functional properties of high-density lipoprotein particles of human blood plasma determining the atheroprotective properties thereof.
1 cl, 3 tbl, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MEASURING THE CONCENTRATION OF CIRCULATING MODIFIED LOW-DENSITY LIPOPROTEINS IN HUMAN BLOOD SERUM | 2016 |
|
RU2659211C2 |
RECOMBINANT DNA PROVIDING IN COMPOSITION OF PLASMID VECTOR SYNTHESIS IN CELLS OF Ecoli OF CHIMERIC PROTEIN - A-I APOLIPOPROTEIN OF HUMAN BEING | 2014 |
|
RU2573930C1 |
METHOD FOR DETECTING OXIDIZING RESISTANCE OF BLOOD PLASMA | 2001 |
|
RU2204834C2 |
METHOD FOR ASSESSING ATHEROGENICITY OF APOLIPOPROTEIN B-CONTAINING LIPOPROTEINS | 2015 |
|
RU2601117C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF CARDIOVASCULAR PATHOLOGY IN DESCENDANTS OF PATIENTS WITH ISCHEMIC CARDIAC DISEASE | 2001 |
|
RU2214597C2 |
METHOD OF LATENT INSULIN RESISTANCE DETECTION | 2008 |
|
RU2367339C1 |
METHOD FOR DETERMINING MINIMUM MODIFIED LIPOPROTEINS OF LOW DENSITY IN SERUM OR PLASMA OF HUMAN BLOOD | 2012 |
|
RU2501013C1 |
AGENT FOR STIMULATING PROLIFERATIVE ACTIVITY OF BONE MARROW CELLS | 2023 |
|
RU2811901C1 |
METHOD FOR CIRCULATING DESIALYLATED LOW DENSITY LIPOPROTEIDS CONTENT ESTIMATION | 2015 |
|
RU2623879C2 |
METHOD OF CONDITION CORRECTION IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY CORRECTION | 2019 |
|
RU2740374C2 |
Authors
Dates
2021-09-16—Published
2020-10-23—Filed